Cancer Research Meeting Calendar  EMT and Cancer Progression and Treatment
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fujii, H.
Right arrow Articles by Shirai, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fujii, H.
Right arrow Articles by Shirai, T.
[Cancer Research 60, 114-120, January 1, 2000]
© 2000 American Association for Cancer Research


Molecular Biology and Genetics

Frequent Genetic Heterogeneity in the Clonal Evolution of Gynecological Carcinosarcoma and Its Influence on Phenotypic Diversity1

Hiroaki Fujii2, Manabu Yoshida, Zhu Xue Gong, Toshiharu Matsumoto, Yoshitomo Hamano, Masaharu Fukunaga, Ralph H. Hruban, Edward Gabrielson and Toshikazu Shirai

Departments of Pathology II [H. F., Z. X. G., Y. H., T. S.], Pathology I [T. M.], and Obstetrics/Gynecology [M. Y.], Juntendo University School of Medicine, Tokyo 113-8421, Japan; Department of Pathology I, Jikei University School of Medicine, Tokyo, Japan [M. F.]; and Departments of Pathology [E. G., R. H. H.] and Oncology Center [E. G.], Johns Hopkins University School of Medicine, Baltimore, Maryland 21287

Carcinosarcomas of the uterus, ovaries, and fallopian tubes are highly aggressive neoplasms with incompletely understood histogenesis. Although recent immunohistochemical, cell culture, and molecular genetic studies all favor these cancers to be monoclonal in origin, the extent of intratumoral genetic heterogeneity in these tumors with divergent histology has not been reported previously. For this study, we microdissected a total of 172 carcinomatous or sarcomatous foci from 17 gynecological carcinosarcomas and analyzed allelic status with 41 microsatellite markers on chromosomal arms 1p, 1q, 3p, 4q, 5q, 6q, 8p, 9p, 10q, 11p, 11q, 13q, 16q, 17p, 17q, 18q, and 22q. With the exception of a single case with microsatellite instability, we found shared allelic losses and retentions among multiple individually dissected foci of each case, strongly supportive of the concept of a monoclonal origin for these neoplasms. In eight of these cases, we also found heterogeneous patterns of allelic loss at limited numbers of chromosomal loci in either the carcinomatous or sarcomatous components of the neoplasms. These heterogeneous patterns of allelic losses were consistent with either genetic progression or genetic diversion occurring during the clonal evolution of these neoplasms. In two cases, we found the specific patterns of genetic progression to be consistent with sarcomatous components of the neoplasms arising from carcinomatous components. We conclude that most of the gynecological carcinosarcomas have a monoclonal origin, and that genetic progression and diversion parallel the development of divergent phenotypes in these tumors. Because phenotypically divergent areas of the tumors share numerous genetic alterations, this divergence most likely occurs relatively late in the evolution of these tumors.




This article has been cited by other articles:


Home page
Am. J. Pathol.Home page
M. Saegusa, M. Hashimura, T. Kuwata, and I. Okayasu
Requirement of the Akt/{beta}-Catenin Pathway for Uterine Carcinosarcoma Genesis, Modulating E-Cadherin Expression Through the Transactivation of Slug
Am. J. Pathol., June 1, 2009; 174(6): 2107 - 2115.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
M. W. Klymkowsky and P. Savagner
Epithelial-Mesenchymal Transition: A Cancer Researcher's Conceptual Friend and Foe
Am. J. Pathol., May 1, 2009; 174(5): 1588 - 1593.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
J. R. Stringer, J. S. Larson, J. M. Fischer, M. Medvedovic, M. N. Hersh, G. P. Boivin, and S. L. Stringer
Modeling variation in tumors in vivo
PNAS, February 15, 2005; 102(7): 2408 - 2413.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Pathol.Home page
H Fujii, K Ichikawa, T Takagaki, Y Nakanishi, M Ikegami, S Hirose, and T Shimoda
Genetic evolution of {alpha} fetoprotein producing gastric cancer
J. Clin. Pathol., December 1, 2003; 56(12): 942 - 949.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
I. Gonzalez-Garcia, R. V. Sole, and J. Costa
Metapopulation dynamics and spatial heterogeneity in cancer
PNAS, October 1, 2002; 99(20): 13085 - 13089.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Pathol.Home page
W G McCluggage
Malignant biphasic uterine tumours: carcinosarcomas or metaplastic carcinomas?
J. Clin. Pathol., May 1, 2002; 55(5): 321 - 325.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2000 by the American Association for Cancer Research.